Literature DB >> 20829176

A fatal case of neonatal adenovirus infection.

Cynthia J Kelley1.   

Abstract

Adenovirus can produce severe disease and even death in the immunocompromised neonate. Symptoms of adenovirus infection are similar to those seen with bacterial infections in neonates, making early recognition and diagnosis difficult. Consideration of adenovirus as a causative agent is important to early diagnosis. Currently available culture techniques, particularly the shell vial culture technique, make more rapid identification of adenovirus infection possible. Early identification and treatment are necessary to improve patient outcomes and prevent the spread of infection to other neonates. Available agents for the treatment of adenovirus have had mixed results, yet their use is preferable to nontreatment of critical patients. This article presents the case of a preterm infant who became fatally ill from disseminated adenoviral infection.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20829176     DOI: 10.1891/0730-0832.29.5.297

Source DB:  PubMed          Journal:  Neonatal Netw        ISSN: 0730-0832


  3 in total

1.  Epidemiology of severe pediatric adenovirus lower respiratory tract infections in Manitoba, Canada, 1991-2005.

Authors:  Saleh Alharbi; Paul Van Caeseele; Raquel Consunji-Araneta; Taoufik Zoubeidi; Sergio Fanella; Abdul-Kader Souid; Ahmed R Alsuwaidi
Journal:  BMC Infect Dis       Date:  2012-03-13       Impact factor: 3.090

2.  Linking digital surveillance and in-depth virology to study clinical patterns of viral respiratory infections in vulnerable patient populations.

Authors:  Patrick E Obermeier; Albert Heim; Barbara Biere; Elias Hage; Maren Alchikh; Tim Conrad; Brunhilde Schweiger; Barbara A Rath
Journal:  iScience       Date:  2022-04-21

Review 3.  Adenoviral Infections in Neonates: A Case-Based Literature Review.

Authors:  Stergiani Keramari; Liana Fidani; Alexandros Poutoglidis; Stefanos Chatzis; Nikolaos Tsetsos; Georgia Kaiafa
Journal:  Cureus       Date:  2022-09-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.